gma semaglutide Medicare's new GLP-1 Bridge program will offer popular weight loss medications at a reduced $50 monthly rate for eligible beneficiaries, making these treatments more affordable and accessible. Read more on this story Demand for weight loss drugs

Research from financial firm TD Cowen found that less than 5% of the 29 million Americans estimated to have alcohol-use disorder receive drug therapy

Introduction GLP1 medications are proving to be one of the most effective non-surgical treatments for obstructive sleep apnea (OSA)

I was reliving the trauma of some really bad situations I had been in

Peptostreptococcus anaerobius induces intracellular cholesterol biosynthesis in colon cells to induce proliferation and causes dysplasia in mice

Studies involving patients with severe organic diseases (e.g., cancer, chronic kidney disease) to avoid confounding effects of underlying conditions on inflammation or depression outcomes